Tucidinostat Plus Apatinib for Advanced Osteosarcoma

Conditions: Osteosarcoma Interventions: Drug: Tucidinostat, Apatinib Sponsors: Wuhan Union Hospital, China Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials